N-acyl-dopamines: Novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo

Biochemical Journal

Volumn 351, Issue 3, 2000, Pages 817-824

  Bisogno, T ^a   Melck, D ^a   Bobrov, M Yu ^a   Gretskaya, N M ^a   Bezuglov, V V ^a   De Petrocellis, L ^a   Di Marzo, V ^a  

^a CNR   (Italy)

Author keywords

Dopamine; Endocannabinoid; FAAH; Transporter; Vanilloid

Indexed keywords

ANANDAMIDE; CANNABINOID RECEPTOR; DOPAMINE; POLYUNSATURATED FATTY ACID;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CHEMICAL STRUCTURE; CONTROLLED STUDY; HYPOTHERMIA; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MEMBRANE TRANSPORT; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BINDING;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; DOPAMINE; FEMALE; LIGANDS; MICE; MICE, INBRED CBA; MOLECULAR MIMICRY; POLYUNSATURATED ALKAMIDES; RATS; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TUMOR CELLS, CULTURED;

EID: 0034332637     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3510817     Document Type: Article

References (50)

1. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: Biochemistry and possible physiopathological relevance
2. Biochemistry of the endogenous ligands of cannabinoid receptors
3. Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid
4. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
5. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
6. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
7. Partial purification and characterization Of the porcine brain enzyme hydrolyzing and synthesizing anandamide
8. Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase'
9. An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors
10. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
11. Anandamide amidohydroiase (fatty acid amide hydrolase)
12. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
13. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusionl
14. Biosynthesis, uptake, and degradation of abandamide and palmitoylethanolamide in leukocytes
15. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes
16. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
17. Molecular characterization of a peripheral receptor for cannabinoids
18. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase
19. Interaction between synthetic vanilloids and the endogenous cannabinoid system
20. Anandamide uptake by human endothelial cells and its regulation by nitric oxide
21. Bioactive amides of fatty acids
22. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
23. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
24. Artificially functionalized polyenoic fatty acids - New lipid bioregulators
25. Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells
26. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)
27. Characterization of resiniferatoxin binding sites on sensory neurons: Co-regulation of resiniferatoxin binding and capsaicin sensitivity in adult rat dorsal root ganglia
28. 2+ in endothelial cells
29. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents
30. The ring test: A quantitative method for assessing the 'cataleptic' effect of cannabis in mice
31. Vanilloids. 1. Analogs of capsaicin with antinociceptive and antiinflammatory activity
32. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
33. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition Of human breast and prostate cancer cell proliferation
34. Biosynthesis and degradation of bioactive fatty acid amides in human breast carcinoma and rat pheochromocytoma cells-implications for cell proliferation and differentiation
35. 2+ transient in NG108-15 cells
36. Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells
37. Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase
38. Cannabimimetic fatty acid derivatives: The anandamide family and other endocannabinoids
39. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells
40. Discovery and characterization of endogenous cannabinoids
41. Pharmacology of cannabinoid CB1 and CB2 receptors
42. Presence of dopamine D-2 receptors in human tumoral cell lines
43. The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells
44. Anandamide may mediate sleep induction
45. Pharmacological effects in mice of anandamide and its related fatty acid ethanolamides, and enhancement of cataleptogenic effect of anandamide by phenylmethylsulfonyl fluoride
46. Anandamide: An endogenous activator o the vanilloid receptor
47. The anandamide transport inhibitor AM404 activates vanilloid receptors
48. The cloned capsaicin receptor integrates multiple pain-producing stimuli
49. Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 2. The amide bond 'B-region'